81 FR 3805 - Arthritis Advisory Committee; Notice of Meeting; Correction

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Federal Register Volume 81, Issue 14 (January 22, 2016)

Page Range3805-3805
FR Document2016-01248

The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register on January 19, 2016 (81 FR 2873). The document announced an ``Arthritis Advisory Committee'' meeting and contained an incorrect date for individuals requesting oral presentations, and for FDA notifying individuals regarding their request to speak at the meeting. This document corrects those errors.

Federal Register, Volume 81 Issue 14 (Friday, January 22, 2016)
[Federal Register Volume 81, Number 14 (Friday, January 22, 2016)]
[Notices]
[Page 3805]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-01248]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2016-N-0001]


Arthritis Advisory Committee; Notice of Meeting; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register on January 19, 2016 (81 FR 2873). 
The document announced an ``Arthritis Advisory Committee'' meeting and 
contained an incorrect date for individuals requesting oral 
presentations, and for FDA notifying individuals regarding their 
request to speak at the meeting. This document corrects those errors.

FOR FURTHER INFORMATION CONTACT: Stephanie L. Begansky, Center for Drug 
Evaluation and Research, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 31, Rm. 2417, Silver Spring, MD 20993-0002, 301-
796-9001, FAX: 301-847-8533.

SUPPLEMENTARY INFORMATION: In FR Doc. 2016-00823, appearing on page 
2873 in the Federal Register of Tuesday, January 19, 2016, the 
following corrections are made:
    1. On page 2873, in the third column, in the ``Procedure'' 
paragraph, the fourth sentence is corrected to read ``Those individuals 
interested in making formal oral presentations should notify the 
contact person and submit a brief statement of the general nature of 
the evidence or arguments they wish to present, the names and addresses 
of proposed participants, and an indication of the approximate time 
requested to make their presentation on or before January 28, 2016.''
    2. On page 2873, in the third column, in the ``Procedure'' 
paragraph, the last sentence is corrected to read ``The contact person 
will notify interested persons regarding their request to speak by 
January 29, 2016.''

    Dated: January 19, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016-01248 Filed 1-21-16; 8:45 am]
BILLING CODE 4164-01-P


Current View
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice; correction.
ContactStephanie L. Begansky, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 31, Rm. 2417, Silver Spring, MD 20993-0002, 301- 796-9001, FAX: 301-847-8533.
FR Citation81 FR 3805 

2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR